The prevalent use of those medications has prompted essential ethical conversations in regards to the medicalization of obesity, access inequities (as these medications are expensive and often not protected by insurance for weight loss), and our societal idea of physique weight.Wegovy® (semaglutide): Administered through a convenient weekly inject